Nava Ltd

Nava Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal codes. The trading window will be shut from July 01, 2026, and will reopen 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026 (Q1FY2027). This measure is standard practice to prevent insider trading during periods when material non-public information may be available.

Nava Ltd announced that its Board of Directors has approved the amalgamation of Nava Healthcare Pte. Ltd. with Nava Global Pte. Ltd., both wholly owned subsidiaries in Singapore. This move is part of an internal reorganization to streamline the company's subsidiary structure. Nava Global Pte. Ltd. holds investments in Energy, Mining, and Metals, while Nava Healthcare Pte. Ltd. focuses on healthcare trading and services. Post-amalgamation, Nava Global Pte. Ltd. will consolidate these investments, aiming to pursue strategic business restructuring, including joint ventures in the healthcare sector to drive growth and long-term value. The transaction is considered a related party transaction and is subject to regulatory approvals.

Nava Ltd's board approved the continuation and re-appointment of three directors during its meeting on May 15, 2026. Mr. Trivikrama Prasad Pinnamaneni will continue as Non-Executive Director for 5 years, effective May 15, 2026. Mr. GRK Prasad was re-appointed as Executive Director for 2 years, effective June 28, 2026. Mr. Mwelwa Chibesakunda was re-appointed as an Independent Director for 5 years, effective November 14, 2026. These appointments are subject to member approval at the Annual General Meeting.

Nava Ltd reports a 116% YoY increase in standalone profit after tax, reaching ₹911 crore for FY26. The company declared a final dividend of ₹5.50 per share, bringing the total dividend for FY26 to ₹8.50 per share. Consolidated profit before tax remained stable, while standalone revenue from operations increased by 19.4% YoY to ₹1925 crore. The company received ₹705 crore from dividends and share buyback during the year.

Nava Ltd's board approved the continuation and re-appointment of three directors during its meeting on May 15, 2026. Mr. Trivikrama Prasad Pinnamaneni will continue as a Non-Executive Director for 5 years, effective May 15, 2026. Mr. GRK Prasad was re-appointed as Executive Director for 2 years, effective June 28, 2026. Mr. Mwelwa Chibesakunda was re-appointed as an Independent Director for 5 years, effective November 14, 2026. These appointments are subject to member approval at the upcoming Annual General Meeting.

Nava Ltd's board has recommended a final dividend of 550%, which is ₹5.50 per equity share with a face value of ₹1 each, for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the upcoming Annual General Meeting and will be paid within the statutory timeline. The board also approved the audited financial results for the quarter and financial year ended March 31, 2026, and considered the re-appointment of directors and alteration of the Memorandum of Association.

Nava Ltd's board approved audited financial results for FY26 and recommended a final dividend of ₹5.50 per equity share. They also approved the continuation/re-appointment of directors and alteration of the Memorandum of Association, subject to shareholder approval. The board also considered the appointment of M/s. Sagar & Associates as Cost Auditors for FY 2026-27.

Nava Ltd's board approved the audited financial results for FY26 and recommended a final dividend of ₹5.50 per equity share. The board also approved the continuation/re-appointment of directors and alteration of the Memorandum of Association. Sagar & Associates were appointed as Cost Auditors for FY 2026-27.

Nava Ltd has announced the grant of 70,000 Restricted Stock Units (RSUs) to eligible employees under the NAVA RSU 2023 plan. The grant, designated as Grant-V, was approved by the Nomination & Remuneration Committee on May 14, 2026. Each RSU allows the holder to apply for one equity share of face value ₹1. The exercise price is ₹555 per RSU, with vesting occurring over four tranches from May 2027 to May 2030. The exercise period is 90 days from the vesting date.

Nava Ltd has scheduled a Board of Directors meeting on May 15, 2026, to consider and approve the audited financial results (Consolidated & Standalone) for the fourth quarter and financial year ending March 31, 2026. The board will also consider and recommend the final dividend for the financial year 2025-26. The trading window, which closed on April 1, 2026, will remain closed until May 17, 2026.